FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21302911000001101: Lapatinib 250mg tablets 105 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71017501000001119 Lapatinib 250mg tablets 105 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71017601000001115 Lapatinib 250mg tablets 105 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lapatinib 250mg tablets 105 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has VMP Lapatinib 250mg tablets true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has VMP Lapatinib 250mg tablets false Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has VMP Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has specific active ingredient Lapatinib ditosylate monohydrate false Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has specific active ingredient Lapatinib ditosylate monohydrate true Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lapatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Is a True Lapatinib 250mg tablets 105 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start